Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / *W EXP 05/24/202
-
Total 13F shares
-
122,121
-
Share change
-
+3,390
-
Total reported value
-
$5,934
-
Price per share
-
$0.04
-
Number of holders
-
8
-
Value change
-
+$70
-
Number of buys
-
3
-
Number of sells
-
2
Institutional Holders of NRX Pharmaceuticals, Inc. - *W EXP 05/24/202 (NRXPW) as of Q3 2024
As of 30 Sep 2024,
NRX Pharmaceuticals, Inc. - *W EXP 05/24/202 (NRXPW) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
122,121 shares.
The largest 8 holders included
TRUIST FINANCIAL CORP, Virtu Financial LLC, TWO SIGMA SECURITIES, LLC, WOLVERINE ASSET MANAGEMENT LLC, UBS Group AG, Johnson Financial Group, Inc., BANK OF AMERICA CORP /DE/, and Tower Research Capital LLC (TRC).
This page lists
8
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.